Related Experiment Video
Updated: May 17, 2026
08:18
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
In vitro dissolution testing of drug-eluting stents
Anne Seidlitz1, Stefan Nagel, Beatrice Semmling
1Institute of Pharmacy, Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, 17487 Greifswald, Germany.
Current Pharmaceutical Biotechnology
|October 25, 2012
Summary
Drug-eluting stents (DES) offer improved outcomes by reducing restenosis. In vitro dissolution testing is crucial for evaluating drug release from DES due to limitations in measuring in vivo levels.
Area of Science:
- Biomedical Engineering
- Pharmacology
- Materials Science
Background:
- Drug-eluting stents (DES) have transformed coronary artery disease treatment, significantly lowering restenosis rates compared to bare-metal stents.
- DES are increasingly utilized in other therapeutic areas, including localized tumor treatment and glaucoma management.
- These stents deliver potent drugs like immunosuppressants or cytostatics in a controlled-release manner over extended periods.
Purpose of the Study:
- To review and discuss current in vitro dissolution testing methods for drug-eluting stents.
- To highlight the unique drug release characteristics of DES based on their composition and in vivo application.
Main Methods:
- Focus on in vitro dissolution testing methodologies.
- Analysis of drug release kinetics from DES.
- Consideration of stent composition and anatomical placement.
Main Results:
- In vitro dissolution testing is a vital tool for assessing DES performance.
- Challenges exist in quantifying in vivo drug levels due to low concentrations and localized delivery.
- Drug release profiles are influenced by stent design and drug formulation.
Conclusions:
- In vitro dissolution testing provides essential insights into DES drug release behavior.
- Understanding these release characteristics is critical for optimizing DES efficacy and safety.
- Further development of standardized in vitro methods is warranted for accurate performance prediction.
Related Concept Videos
01:17In Vitro Drug Dissolution: Alternative Methods
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
01:09In Vitro Drug Dissolution: Compendial Testing Models II
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
01:10In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
01:13In Vitro Drug Dissolution: Compendial Testing Models I
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
01:14Drug Dissolution: Requirements and Profile Comparison
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
01:15Theories of Dissolution: Diffusion Layer Model
Dissolution, the process by which drug particles dissolve in a solvent, is explained by the diffusion layer model, a theoretical framework that simulates the absorption of oral drugs and allows us to analyze experimental data.
This process starts with a thin layer, saturated with the drug, forming at the interface between the solid and liquid. The solute then diffuses from this layer into the main solution. The Noyes-Whitney equation suggests that the rate of dissolution relies on the diffusion...
This process starts with a thin layer, saturated with the drug, forming at the interface between the solid and liquid. The solute then diffuses from this layer into the main solution. The Noyes-Whitney equation suggests that the rate of dissolution relies on the diffusion...